ArticleProceedings of the National Academy of Sciences of the United States of America2020

Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.

Siddhant U Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.